Woodmont Investment Counsel LLC Harvard Bioscience Inc Transaction History

Woodmont Investment Counsel LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$2.77 - $4.38 $169,842 - $268,559	-61,315 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$5.0 - $6.65 $168,025 - $223,473	-33,605 Reduced 35.4%	61,315 $322,000
Q2 2018 Aug 10, 2018	SELL	$4.2 - $5.95 $74,340 - $105,315	-17,700 Reduced 15.72%	94,920 $508,000
Q1 2018 May 14, 2018	SELL	$3.3 - $5.15 $209,454 - $326,875	-63,471 Reduced 36.04%	112,620 $563,000
Q4 2017 Feb 13, 2018	SELL	$3.08 - $3.8 $4,312 - $5,320	-1,400 Reduced 0.79%	176,091 $581,000
Q3 2017 Nov 13, 2017	BUY	$2.7 - $3.75 $479,225 - $665,591	177,491	177,491 $666,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Woodmont Investment Counsel LLC, based on Form 13F filings with the SEC.

Stay updated on Woodmont Investment Counsel LLC with notifications on news.